14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $4.43 $8.62 Wednesday, 28th Feb 2024 FATE stock ended at $7.14. This is 4.29% less than the trading day before Tuesday, 27th Feb 2024. During the day the stock fluctuated 15.55% from a day low at $7.07 to a day high of $8.17.
90 days $2.10 $8.62
52 weeks $1.63 $8.62

Historical Fate Therapeutics prices

Date Open High Low Close Volume
2024-02-28 $7.36 $8.17 $7.07 $7.14 3 450 520
2024-02-27 $7.56 $8.62 $6.71 $7.46 4 062 728
2024-02-26 $6.96 $7.17 $6.67 $6.95 2 086 850
2024-02-23 $6.86 $7.11 $6.75 $6.96 1 507 544
2024-02-22 $6.92 $7.04 $6.62 $6.88 1 921 708
2024-02-21 $7.03 $7.09 $6.47 $6.83 1 635 594
2024-02-20 $7.36 $7.60 $6.79 $7.06 2 723 240
2024-02-16 $7.00 $7.73 $6.87 $7.56 2 532 023
2024-02-15 $6.63 $7.20 $6.52 $7.08 2 872 440
2024-02-14 $6.58 $6.60 $6.21 $6.49 1 309 115
2024-02-13 $6.39 $6.54 $6.17 $6.39 1 930 430
2024-02-12 $6.31 $6.88 $6.19 $6.86 2 497 618
2024-02-09 $6.16 $6.30 $5.96 $6.29 2 145 592
2024-02-08 $5.58 $6.16 $5.49 $6.11 2 802 264
2024-02-07 $5.78 $5.85 $5.54 $5.56 1 840 668
2024-02-06 $6.33 $6.33 $5.29 $5.74 3 565 509
2024-02-05 $6.36 $6.64 $5.59 $6.36 3 097 754
2024-02-02 $6.70 $6.83 $6.19 $6.52 3 895 971
2024-02-01 $6.24 $6.89 $6.04 $6.76 6 184 799
2024-01-31 $5.52 $6.64 $5.47 $6.16 6 694 150
2024-01-30 $5.64 $5.77 $5.42 $5.58 2 777 392
2024-01-29 $4.56 $5.95 $4.43 $5.72 7 282 103
2024-01-26 $4.63 $4.69 $4.44 $4.56 1 397 337
2024-01-25 $4.66 $4.80 $4.40 $4.56 1 586 435
2024-01-24 $4.97 $4.98 $4.59 $4.61 2 651 389
Click to get the best stock tips daily for free!

About Fate Therapeutics

Fate Therapeutics Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT